| Literature DB >> 35053833 |
Dorota Frydecka1, Patryk Piotrowski2, Tomasz Bielawski1, Edyta Pawlak3, Ewa Kłosińska4, Maja Krefft1, Kamila Al Noaimy1, Joanna Rymaszewska1, Ahmed A Moustafa5,6, Jarosław Drapała7, Błażej Misiak2.
Abstract
A large body of research attributes learning deficits in schizophrenia (SZ) to the systems involved in value representation (prefrontal cortex, PFC) and reinforcement learning (basal ganglia, BG) as well as to the compromised connectivity of these regions. In this study, we employed learning tasks hypothesized to probe the function and interaction of the PFC and BG in patients with SZ-spectrum disorders in comparison to healthy control (HC) subjects. In the Instructed Probabilistic Selection task (IPST), participants received false instruction about one of the stimuli used in the course of probabilistic learning which creates confirmation bias, whereby the instructed stimulus is overvalued in comparison to its real experienced value. The IPST was administered to 102 patients with SZ and 120 HC subjects. We have shown that SZ patients and HC subjects were equally influenced by false instruction in reinforcement learning (RL) probabilistic task (IPST) (p-value = 0.441); however, HC subjects had significantly higher learning rates associated with the process of overcoming cognitive bias in comparison to SZ patients (p-value = 0.018). The behavioral results of our study could be hypothesized to provide further evidence for impairments in the SZ-BG circuitry; however, this should be verified by neurofunctional imaging studies.Entities:
Keywords: confirmation bias; instructed reinforcement learning; schizophrenia
Year: 2022 PMID: 35053833 PMCID: PMC8773670 DOI: 10.3390/brainsci12010090
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Figure 1Probabilistic contingencies during training phase of IPST AB (90%/15%), CD (80%/30%), EF (80%/30%), and GH (70%/45%) conditions and trial examples with negative and positive feedback.
General demographic and clinical characteristic of schizophrenia (SZ) patients and healthy control (HC) participants.
| Category | Variable | SZ | HC | |
|---|---|---|---|---|
| Demographic information | Age (years) | 38.19 ± 13.81 | 36.80 ± 13.34 | 0.528 1 |
| Sex (M/F) | 5712/45 | 45/75 | 0.005 | |
| Educational level (%) | - | - | <0.001 | |
| Primary | 19.8% | 11.7% | ||
| Vocational | 9.9% | 0.0% | ||
| Secondary | 44% | 48.7% | ||
| Higher | 26.4% | 39.6% | ||
| Neurocognition (mean ± SD) | RBANS—immediate memory | 38.78 ± 11.20 | 50.66 ± 7.08 | <0.001 2 |
| RBANS—visuospatial and constructional | 33.06 ± 6.51 | 37.24 ± 3.27 | <0.001 2 | |
| RBANS—language | 28.55 ± 6.73 | 34.61 ± 6.71 | <0.001 1 | |
| RBANS—attention | 43.99 ± 13.40 | 63.66 ± 14.10 | <0.001 1 | |
| RBANS—delayed memory | 42.38 ± 11.57 | 54.21 ± 5.86 | <0.001 2 | |
| RBANS—total score | 187.25 ± 39.88 | 240.67 ± 29.17 | <0.001 2 | |
| Clinical ratings (mean ± SD) | Age of onset | 24.82 ± 7.42 | - | - |
| Illness duration | 12.13 ± 10.56 | - | - | |
| BPRS | 40.02 ± 10.48 | - | - | |
| PANSS—positive symptoms | 13.34 ± 4.71 | - | - | |
| PANSS—negative symptoms | 21.04 ± 9.60 | - | - | |
| PANSS—general symptoms | 29.35 ± 7.97 | - | - | |
| SANS | 33.46 ± 22.84 | - | - | |
| SAPS | 20.09 ± 20.19 | - | - | |
| MADRS | 8.33 ± 9.00 | - | - | |
| GAF | 47.08 ± 20.54 | - | - | |
| Antipsychotic medication (mean ± SD) | CPZeq | 501.98 ± 340.52 | - | - |
1 parametric test, 2 non-parametric test, abbreviations: RBANS—Repeatable Battery for the Assessment of Neuropsychological Status; BPRS—Brief Psychiatric Rating Scale; PANSS—Positive and Negative Syndrome Scale; SANS—Scale for the Assessment of Negative Symptoms; SAPS—Scale for the Assessment of Positive Symptoms; MADRS—Montgomery–Asberg Depression Rating Scale; GAF—Global Assessment of Functioning scale; CPZeq—chlorpromazine equivalent, SD—Standard Deviation, SZ—schizophrenia-spectrum patients; HC—healthy control participants.
Figure 2Comparison of acquisition of probabilistic contingencies during IPST for AB (90%/15%), CD (80%/30%), EF (80%/30%), and GH (70%/45%) conditions between schizophrenia (SZ) patients and healthy control (HC) participants. Green color refers to HC participants and blue color refers to the patients with SZ, * refers to statistically significant differences.
Figure 3Comparison of performance during the training phase of IPST among schizophrenia (SZ) patients and healthy control (HC) participants: (a) first and last 10 trials of uninstructed CD (80%/30%) condition; (b) first and last 10 trials of instructed EF (80%/30%) condition. Green color refers to HC participants and blue color refers to the patients with SZ.
Figure 4The effect of interaction of group (patients with SZ and HC subjects) and the difference between the first 10 and last 10 trials of the CD (80%/30%) and EF (80%/30%) conditions of the training phase of the IPST. Green color refers to HC participants and blue color refers to patients with SZ.
Figure 5Diagram depicting neural network accounts of instructional control over reinforcement learning. Red lines indicate projections with differing computational roles. Instruction representations from PFC via top-down projections either directly bias the BG valuation, selection, and learning (bias model), or override BG learning of probabilities through the competition at motor cortex (override model) (red line). Bottom-up connections between BG and PFC enable updating of the cortical value of falsely instructed stimuli (green line).